🇪🇸 Spain Country × Condition
alzheimer disease Clinical Trials in Spain
Active clinical trials for alzheimer disease with research sites in Spain. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 3 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇪🇸 Spain
Active Trials in Spain (2)
NCT07234695 Phase 3
Recruiting
LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome
Enrollment
120 pts
Country
🇪🇸 Spain
Fundació Institut de Recerca de l'H...
View Trial → NCT07025070
Recruiting
The Link Between Physical Activity and Brain Health in Healthy Adults
Enrollment
60 pts
Country
🇪🇸 Spain
Technical University of Madrid
View Trial → Frequently Asked Questions
How many alzheimer disease clinical trials are active in Spain?
There are currently 2 active clinical trials for alzheimer disease with sites in Spain, of which 2 are actively recruiting patients.
How can I join a alzheimer disease clinical trial in Spain?
To join a alzheimer disease clinical trial in Spain, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Spain directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are alzheimer disease trials in Spain?
Active alzheimer disease trials in Spain span Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology